194 related articles for article (PubMed ID: 1959370)
1. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis.
Davies SP; Reaveley DA; Brown EA; Kox WJ
Crit Care Med; 1991 Dec; 19(12):1510-5. PubMed ID: 1959370
[TBL] [Abstract][Full Text] [Related]
2. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
[TBL] [Abstract][Full Text] [Related]
3. Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute renal failure.
Hynote ED; McCamish MA; Depner TA; Davis PA
JPEN J Parenter Enteral Nutr; 1995; 19(1):15-21. PubMed ID: 7658594
[TBL] [Abstract][Full Text] [Related]
4. Amino acid losses during sustained low efficiency dialysis in critically ill patients with acute kidney injury.
Umber A; Wolley MJ; Golper TA; Shaver MJ; Marshall MR
Clin Nephrol; 2014 Feb; 81(2):93-9. PubMed ID: 24290407
[TBL] [Abstract][Full Text] [Related]
5. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients.
Merrill RH
J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute renal failure in an infant by continuous arteriovenous hemodialysis.
Assadi FK
Pediatr Nephrol; 1988 Jul; 2(3):320-2. PubMed ID: 3153035
[TBL] [Abstract][Full Text] [Related]
7. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.
Bonnardeaux A; Pichette V; Ouimet D; Geadah D; Habel F; Cardinal J
Am J Kidney Dis; 1992 Jan; 19(1):31-8. PubMed ID: 1739079
[TBL] [Abstract][Full Text] [Related]
8. Continuous arteriovenous haemodiafiltration in the critically ill: influence on major nutrient balances.
Bellomo R; Martin H; Parkin G; Love J; Kearley Y; Boyce N
Intensive Care Med; 1991; 17(7):399-402. PubMed ID: 1774393
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin clearance during continuous arteriovenous hemodiafiltration.
Ernest D; Cutler DJ
Crit Care Med; 1992 May; 20(5):586-9. PubMed ID: 1572182
[TBL] [Abstract][Full Text] [Related]
10. Amino acid balance with extended daily diafiltration in acute kidney injury.
Chua HR; Baldwin I; Fealy N; Naka T; Bellomo R
Blood Purif; 2012; 33(4):292-9. PubMed ID: 22652535
[TBL] [Abstract][Full Text] [Related]
11. "Machineless" nutritional hemodialysis.
Roberts M; Barney MH; Trott MA; Montez AJ; Stephens VM; Lee DB
ASAIO Trans; 1989; 35(3):270-3. PubMed ID: 2512967
[TBL] [Abstract][Full Text] [Related]
12. Solute transport in continuous hemodialysis: a new treatment for acute renal failure.
Sigler MH; Teehan BP
Kidney Int; 1987 Oct; 32(4):562-71. PubMed ID: 3430952
[TBL] [Abstract][Full Text] [Related]
13. High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome.
Pichette V; Leblanc M; Bonnardeaux A; Ouimet D; Geadah D; Cardinal J
Am J Kidney Dis; 1994 Apr; 23(4):591-6. PubMed ID: 8154498
[TBL] [Abstract][Full Text] [Related]
14. Amino acid losses and nitrogen balance during slow diurnal hemodialysis in critically ill patients with renal failure.
Kihara M; Ikeda Y; Fujita H; Miura M; Masumori S; Tamura K; Yabana M; Takagi N; Umemura S; Ishii M
Intensive Care Med; 1997 Jan; 23(1):110-3. PubMed ID: 9037649
[TBL] [Abstract][Full Text] [Related]
15. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
Bellomo R; McGrath B; Boyce N
Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
[TBL] [Abstract][Full Text] [Related]
16. Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis.
Schmidt JJ; Hafer C; Spielmann J; Hadem J; Schönenberger E; Schmidt BM; Kielstein JT
Nephron Clin Pract; 2014; 126(1):62-6. PubMed ID: 24577340
[TBL] [Abstract][Full Text] [Related]
17. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
[TBL] [Abstract][Full Text] [Related]
18. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).
Vos MC; Vincent HH; Yzerman EP
Intensive Care Med; 1992; 18(5):282-5. PubMed ID: 1527259
[TBL] [Abstract][Full Text] [Related]
19. Continuous arteriovenous hemodialysis: outcome in intensive care acute renal failure patients.
Alarabi AA; Danielson BG; Wikström B
Nephron; 1993; 64(1):58-62. PubMed ID: 8502337
[TBL] [Abstract][Full Text] [Related]
20. Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment.
Gouyon JB; Desgres J; Mousson C
Pediatr Res; 1994 Mar; 35(3):357-61. PubMed ID: 8190527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
